ICD-10: M11.062

Hydroxyapatite deposition disease, commonly referred to as calcific tendinitis or calcific shoulder, is characterized by the deposition of hydroxyapatite crystals in the soft tissues, particularly around joints and tendons. The ICD-10-CM code M11.062 specifically denotes this condition when it affects the left knee.

Clinical Description

Definition

Hydroxyapatite deposition disease involves the accumulation of hydroxyapatite crystals, which are calcium phosphate crystals, in the connective tissues. This condition can lead to inflammation, pain, and restricted movement in the affected joint. While it is most frequently associated with the shoulder, it can also occur in other joints, including the knee.

Symptoms

Patients with hydroxyapatite deposition disease in the left knee may experience:
- Localized Pain: Often severe and can be exacerbated by movement or pressure on the knee.
- Swelling: Inflammation around the knee joint may lead to visible swelling.
- Stiffness: Reduced range of motion due to pain and inflammation.
- Tenderness: The area around the knee may be sensitive to touch.

Diagnosis

Diagnosis typically involves:
- Clinical Examination: Assessment of symptoms and physical examination of the knee.
- Imaging Studies: X-rays or ultrasound may reveal calcifications in the soft tissues around the knee joint, confirming the presence of hydroxyapatite deposits.
- MRI: In some cases, MRI may be used to assess the extent of the disease and to rule out other conditions.

Treatment

Management of hydroxyapatite deposition disease may include:
- Conservative Measures: Rest, ice application, and non-steroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation.
- Physical Therapy: Exercises to improve range of motion and strengthen the surrounding muscles.
- Injections: Corticosteroid injections may be administered to alleviate severe inflammation.
- Surgical Intervention: In persistent cases that do not respond to conservative treatment, surgical removal of the deposits may be considered.

Conclusion

The ICD-10 code M11.062 is crucial for accurately documenting and billing for hydroxyapatite deposition disease affecting the left knee. Understanding the clinical presentation, diagnostic methods, and treatment options is essential for healthcare providers to manage this condition effectively. Proper coding ensures that patients receive appropriate care and that healthcare providers are reimbursed for their services.

Hydroxyapatite deposition disease (HADD), classified under ICD-10 code M11.062, primarily affects the joints and is characterized by the deposition of hydroxyapatite crystals in the synovial fluid and surrounding tissues. This condition can lead to a range of clinical presentations, signs, symptoms, and patient characteristics, particularly when it involves the left knee.

Clinical Presentation

Overview

HADD is often associated with acute or chronic joint pain and inflammation. The left knee, being a common site for this condition, may exhibit specific symptoms that can significantly impact a patient's quality of life.

Signs and Symptoms

1. Joint Pain: Patients typically experience localized pain in the left knee, which may be acute or chronic. The pain can be exacerbated by movement or weight-bearing activities[1].

2. Swelling: Inflammation in the knee joint can lead to noticeable swelling, which may be accompanied by warmth and tenderness upon palpation[1].

3. Stiffness: Patients often report stiffness in the knee, particularly after periods of inactivity or in the morning, which can limit mobility and function[1].

4. Reduced Range of Motion: The accumulation of hydroxyapatite crystals can restrict the range of motion in the knee, making it difficult for patients to fully extend or flex the joint[1].

5. Crepitus: Some patients may experience a grinding or popping sensation during movement, known as crepitus, due to the presence of crystals in the joint[1].

6. Acute Attacks: HADD can present with acute episodes of severe pain and swelling, mimicking other forms of arthritis, such as gout or pseudogout[1].

Patient Characteristics

• Age: HADD is more commonly observed in middle-aged to older adults, typically between the ages of 40 and 70[1].

• Gender: There is a slight male predominance in the incidence of HADD, although it can affect both genders[1].

• Comorbidities: Patients with a history of metabolic disorders, such as hypercalcemia or chronic kidney disease, may be at higher risk for developing HADD due to altered calcium metabolism[1].

• Activity Level: Individuals who engage in repetitive knee activities or have a history of knee injuries may be more susceptible to the development of hydroxyapatite deposition disease[1].

• Family History: A familial predisposition may exist, suggesting a genetic component to the disease[1].

Conclusion

Hydroxyapatite deposition disease in the left knee presents with a distinct set of clinical features, including joint pain, swelling, stiffness, and reduced range of motion. Understanding the signs and symptoms, along with patient characteristics, is crucial for accurate diagnosis and effective management. Clinicians should consider HADD in patients presenting with knee pain, particularly in those with risk factors or a history of joint issues. Early intervention can help alleviate symptoms and improve the patient's quality of life.

Hydroxyapatite deposition disease, specifically coded as M11.062 in the ICD-10 classification, is a condition characterized by the accumulation of hydroxyapatite crystals in the soft tissues around joints, particularly affecting the knee. This condition can lead to pain and inflammation, often mimicking other forms of arthritis.

Alternative Names

Hydroxyapatite deposition disease may be referred to by several alternative names, including:

• Calcific Tendonitis: This term is often used when the deposition occurs in the tendons, particularly around the shoulder or knee.
• Hydroxyapatite Crystal Disease: A broader term that encompasses the deposition of hydroxyapatite crystals in various tissues.
• Chondrocalcinosis: Although primarily associated with calcium pyrophosphate dihydrate (CPPD) crystals, it can sometimes be confused with hydroxyapatite deposition.
• Crystal-Induced Arthritis: A general term that includes various types of arthritis caused by crystal deposits, including hydroxyapatite.

Related Terms

In addition to alternative names, several related terms and concepts are associated with hydroxyapatite deposition disease:

• Calcific Bursitis: Inflammation of the bursa due to calcific deposits, which can occur in conjunction with hydroxyapatite deposition.
• Tendinopathy: A general term for tendon disorders that may be related to hydroxyapatite deposits affecting tendon function.
• Osteoarthritis: While distinct, osteoarthritis can coexist with hydroxyapatite deposition disease, complicating the clinical picture.
• Synovitis: Inflammation of the synovial membrane, which can occur due to the irritation caused by hydroxyapatite crystals.

Conclusion

Understanding the alternative names and related terms for ICD-10 code M11.062 is crucial for accurate diagnosis and treatment. These terms help healthcare professionals communicate effectively about the condition and its implications for patient care. If you have further questions or need more specific information, feel free to ask!

Hydroxyapatite deposition disease, commonly referred to as calcific tendinitis or calcific bursitis, is characterized by the deposition of hydroxyapatite crystals in the soft tissues, particularly around joints. The ICD-10 code M11.062 specifically denotes this condition in the left knee. The diagnosis of hydroxyapatite deposition disease involves several criteria, which can be categorized into clinical, radiological, and laboratory assessments.

Clinical Criteria

1. Symptoms: Patients typically present with localized pain, swelling, and tenderness around the affected joint, in this case, the left knee. The pain may be acute or chronic and can be exacerbated by movement or pressure on the joint.

2. Physical Examination: A thorough physical examination is essential. The clinician may observe swelling, warmth, and limited range of motion in the left knee. Tenderness over the joint or surrounding soft tissues is also a common finding.

3. History of Symptoms: A detailed patient history is crucial. The onset of symptoms, duration, and any previous episodes of similar pain or joint issues should be documented. A history of trauma or overuse may also be relevant.

Radiological Criteria

1. Imaging Studies: Radiographic imaging is a key component in diagnosing hydroxyapatite deposition disease. X-rays typically reveal calcifications in the soft tissues around the knee joint, particularly in the tendons or bursae. In some cases, ultrasound or MRI may be utilized to provide a more detailed view of the soft tissue involvement and to confirm the presence of hydroxyapatite crystals.

2. Characteristic Findings: On X-ray, the presence of well-defined calcific deposits in the soft tissues adjacent to the knee joint is indicative of hydroxyapatite deposition disease. These deposits may appear as radiopaque areas on the imaging studies.

Laboratory Criteria

1. Exclusion of Other Conditions: Laboratory tests may be performed to rule out other conditions that could mimic hydroxyapatite deposition disease, such as gout or pseudogout. This may include serum uric acid levels and other inflammatory markers.

2. Synovial Fluid Analysis: In some cases, aspiration of the joint may be performed to analyze synovial fluid. The presence of hydroxyapatite crystals can be confirmed through polarized light microscopy, although this is less commonly done.

Conclusion

The diagnosis of hydroxyapatite deposition disease (ICD-10 code M11.062) in the left knee is based on a combination of clinical symptoms, physical examination findings, radiological evidence, and laboratory tests to exclude other conditions. A comprehensive approach ensures accurate diagnosis and appropriate management of this condition, which can significantly impact a patient's quality of life if left untreated. If you have further questions or need more specific information, feel free to ask!

Hydroxyapatite deposition disease, commonly referred to as calcific tendinitis or calcific shoulder, is characterized by the deposition of hydroxyapatite crystals in the tendons, leading to inflammation and pain. When this condition affects the left knee, it is classified under the ICD-10 code M11.062. The treatment approaches for this condition typically involve a combination of conservative management, interventional procedures, and, in some cases, surgical options.

Conservative Management

1. Rest and Activity Modification

• Rest: Patients are advised to rest the affected knee to reduce inflammation and pain. Avoiding activities that exacerbate symptoms is crucial.
• Activity Modification: Gradual return to activities, focusing on low-impact exercises, can help maintain joint function without aggravating the condition.

2. Physical Therapy

• Strengthening Exercises: Targeted exercises can help strengthen the muscles around the knee, providing better support and stability.
• Range of Motion Exercises: Gentle stretching and mobility exercises can improve flexibility and reduce stiffness in the knee joint.

3. Medications

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Medications such as ibuprofen or naproxen can help alleviate pain and reduce inflammation.
• Corticosteroids: In some cases, corticosteroid injections may be administered to provide temporary relief from severe inflammation.

Interventional Procedures

1. Aspiration

• Joint Aspiration: In cases where there is significant swelling or fluid accumulation, aspiration may be performed to remove excess fluid and relieve pressure on the joint.

2. Extracorporeal Shock Wave Therapy (ESWT)

• Shock Wave Therapy: This non-invasive treatment uses sound waves to promote healing and reduce pain in the affected area. It can be particularly effective in cases of calcific tendinitis.

3. Ultrasound-Guided Injection

• Hydroxyapatite Injection: In some instances, ultrasound-guided injections of hydroxyapatite may be used to directly target the calcifications, potentially aiding in their resolution.

Surgical Options

1. Arthroscopy

• Minimally Invasive Surgery: If conservative treatments fail, arthroscopic surgery may be considered. This procedure allows for direct visualization and removal of calcific deposits from the knee joint.

2. Open Surgery

• Open Surgical Intervention: In rare cases, open surgery may be necessary to address extensive calcifications or to repair any associated damage to the knee structures.

Conclusion

The management of hydroxyapatite deposition disease in the left knee (ICD-10 code M11.062) typically begins with conservative approaches, including rest, physical therapy, and medications. If these methods do not provide sufficient relief, interventional procedures such as aspiration or shock wave therapy may be employed. Surgical options are reserved for cases that do not respond to less invasive treatments. It is essential for patients to work closely with their healthcare providers to develop a tailored treatment plan that addresses their specific needs and symptoms.